ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.7919
0.00%
Brent Oil
80.005
0.00%
Bitcoin
103,101.79
-0.98%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Xeris Biopharma Holdings Inc (XERS) Cotización

Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings Inc (XERS)

NASDAQ
3.20
-0.02
(-0.62%)
Cerrado 18 Enero 3:00PM
Delayed by 15 minutes
3.2371
0.0371
(1.16%)
Fuera de horario: 5:13PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
3.2371
Postura de Compra
3.19
Postura de Venta
3.28
Volume Operado de la Acción
893,052
3.15 Rango del Día 3.255
1.69 Rango de 52 semanas 3.87
Capitalización de Mercado [m]
482.592M
Precio Anterior
3.22
Precio de Apertura
3.24
Hora
310
@
3.2371
(formt)
Última hora de negociación
Volumen financiero
US$ 2,848,865
Precio Promedio Ponderado
3.19
Volumen promedio (3 m)
1,680,462
Acciones en circulación
149,081,461
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-7.64
Beneficio por acción (BPA)
-0.42
turnover
163.91M
Beneficio neto
-62.26M

Acerca de Xeris Biopharma Holdings Inc

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalem... Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company markets Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.xerispharma.com
Sede
Wilmington, Delaware, USA
Fundado
-
Xeris Biopharma Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XERS. The last closing price for Xeris Biopharma was US$3.22. Over the last year, Xeris Biopharma shares have traded in a share price range of US$ 1.69 to US$ 3.87.

Xeris Biopharma currently has 149,081,461 shares in issue. The market capitalisation of Xeris Biopharma is US$480.04 million. Xeris Biopharma has a price to earnings ratio (PE ratio) of -7.64.

XERS Últimas noticias

Más noticias

Form 8-K - Current report

10 Enero 2025
Edgar (US Regulatory)

Xeris Expects to Exceed Full-Year 2024 Financial Guidance

Full-year 2024 total revenue projected to be $203 million, exceeding previous guidance of $198-$202 million Year-end 2024 cash position expected to be over $71 million, generating positive cash...

10 Enero 2025
Business Wire

Form 4 - Statement of changes in beneficial ownership of securities

07 Enero 2025
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

07 Enero 2025
Edgar (US Regulatory)

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a...

06 Enero 2025
Business Wire

Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing innovative products across a...

26 Noviembre 2024
Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

08 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

08 Noviembre 2024
Edgar (US Regulatory)

Xeris Biopharma Reports Third Quarter 2024 Financial Results

Achieved record total revenue of $54.3M including record product revenue of $52.9M Product revenue increased 27% versus prior year and 14% over the prior quarter Ended Q3 with $69.4M in cash...

08 Noviembre 2024
Business Wire

Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024

Conference call and webcast at 8:30am ET Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and...

31 Octubre 2024
Business Wire
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.1329-3.943620178043.373.5953.1416513463.29923321CS
4-0.1129-3.370149253733.353.673.1413747443.39356738CS
12-0.0129-0.3969230769233.253.872.8216804623.33937711CS
260.707127.94861660082.533.872.09515651983.0038495CS
520.637124.50384615382.63.871.6916053272.68032381CS
1561.007145.16143497762.233.870.970114058012.27813689CS
260-3.1129-49.02204724416.357.940.970118358013.06626603CS

XERS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Xeris Biopharma?
El precio actual de las acciones de Xeris Biopharma es US$ 3.2371
¿Cuántas acciones de Xeris Biopharma están en circulación?
Xeris Biopharma tiene 149,081,461 acciones en circulación
¿Cuál es la capitalización de mercado de Xeris Biopharma?
La capitalización de mercado de Xeris Biopharma es USD 480.04M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Xeris Biopharma?
Xeris Biopharma ha negociado en un rango de US$ 1.69 a US$ 3.87 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Xeris Biopharma?
El ratio precio/beneficio de Xeris Biopharma es -7.64
¿Cuál es el ratio de efectivo a ventas de Xeris Biopharma?
El ratio de efectivo a ventas de Xeris Biopharma es 2.9
¿Cuál es la moneda de reporte de Xeris Biopharma?
Xeris Biopharma presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Xeris Biopharma?
El último ingresos anual de Xeris Biopharma es USD 163.91M
¿Cuál es el último beneficio anual de Xeris Biopharma?
El último beneficio anual de Xeris Biopharma es USD -62.26M
¿Cuál es la dirección registrada de Xeris Biopharma?
La dirección registrada de Xeris Biopharma es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Xeris Biopharma?
La dirección del sitio web de Xeris Biopharma es www.xerispharma.com
¿En qué sector industrial opera Xeris Biopharma?
Xeris Biopharma opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

XERS Discussion

Ver más
81vette 81vette 1 mes hace
8 month trend is tremendously strong in this market!!
👍️0
Firestorm22 Firestorm22 2 meses hace
Seems a lot like all the hyped pump and dump stocks. I see the same hype from people posting but no results…..hmmmmmm
👍️0
Rkrocks Rkrocks 3 meses hace
Monk things starting to take shape
👍️0
Pascal2 Pascal2 6 meses hace
We need to rebound to 3 first. Back to level. Normal And to 4. Is possible ..
👍️0
Monksdream Monksdream 10 meses hace
XERS under $3
👍️0
StocksNcash StocksNcash 10 meses hace
Still here👍
👍️0
Frankestin Frankestin 10 meses hace
We are ready?🙏
👍️0
Nadendla Nadendla 11 meses hace
ya..:)
👍️0
StocksNcash StocksNcash 11 meses hace
Your welcome
👍️0
buccaneer1961 buccaneer1961 11 meses hace
Thankyou!
👍️0
StocksNcash StocksNcash 11 meses hace
Not really sure, but there has been positive news on this company. My app tip ranks has a forecast $51!! I’m holding lol good luck
👍️0
TrendTrade2016 TrendTrade2016 11 meses hace
XERS...3.29 BREAK OUT COMING UP
👍️0
buccaneer1961 buccaneer1961 11 meses hace
Green lately..whats the catalysts?
👍️0
StocksNcash StocksNcash 11 meses hace
Buy hold and don’t look back$$$$$
👍️0
Monksdream Monksdream 11 meses hace
XERS new 52 week high
👍️0
Rkrocks Rkrocks 2 años hace
Let’s hope to break 3.00 soon
👍️0
price_and_volume price_and_volume 3 años hace
Izzy Englander likes $XERS...

https://finance.yahoo.com/news/billionaire-israel-englander-pulls-trigger-133848525.html
👍️0
mess124 mess124 3 años hace
Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after

Strongbridge vanished and XERS showed up.


Thank you
👍️0
Elgordo84 Elgordo84 3 años hace
Yes indeed
👍️0
alchemytrader alchemytrader 3 años hace
Nice catch in the low 2.00s.
👍️0
Elgordo84 Elgordo84 3 años hace
Goodluck to all the Longs!
👍️0
$Money Bags$ $Money Bags$ 3 años hace
Ramping up for sure.
👍️0
Elgordo84 Elgordo84 3 años hace
I like what I see here!

Looks like a Trend reversal

Great with patience!

Let’s go $XERS

#EG84
👍️0
ahimsa27 ahimsa27 3 años hace
PDUFA New Years ?
👍️0
$Money Bags$ $Money Bags$ 3 años hace
They stalled the run when they first announced the merger, then silently listed their failed FDA trial in that q. They have more stuff in the pipeline and once the merger is done, maybe they can ramp revenue.
👍️0
ezyE ezyE 3 años hace
Can we make it rain here?
👍️0
kzivann kzivann 3 años hace
Premarket action .. nice news.


XERS
👍️0
tknuncle tknuncle 3 años hace
Where is the bottom to XERS? I grabbed a a couple hundred a few days ago and it just keeps dropping more an more. Even after the good news today and yesterday. I was hoping maybe someone had an opinion they would like to share. Also does anyone know the real OS or Float? When I look at the OTC website I see it hasn't been updated since March 22nd.

https://www.otcmarkets.com/stock/SLS/security

Thanks for any feed back. Much appreciated
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Item 5.

Ownership of 5 Percent or Less of a Class. If this statement is being
filed to report the fact that as of the date hereof the reporting person
has ceased to be the beneficial owner of more than 5 percent of the
class of securities, check the following [ X ].
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Blackrock sold 2.1m shares into it since their last filing in May until today. If they are done suppressing it now, maybe it can finally head north to where it belongs.
👍️0
Modlich Modlich 4 años hace
Company on verge of bullish long run consolidated after bull flag bo last 2 days, imo anything over 5.2
and this could easily hit 7.8, breaks that or news stock can easily reach double digits.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Nom nom nom bring the gains.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
They are acquiring another company, which pushed the profitability timeline back and it reflected in that. That said, it'll cross the threshold a little harder. Some nice gains whether flipping or bottom feeding long.
👍️0
harr449 harr449 4 años hace
Recent announcement of deal caused PT to go from $14 to $9.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
You guys enjoying the start of this nice run?
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Delicious.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Once these conversions clear the landscape will probably change quick. I would think we are close too, but...
👍️0
I Dump I Dump 4 años hace
Falcon stocks has them as a buy this week. Holding off yet. Maybe bottom is near.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
So many conversions knocking the floor out of this thing. One day, pow, right in the kisser.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Conversions on this are still brutal. Float is low, one day she breaks the chains.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Must be looming conversions. Company events looking good.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Must be looming conversions. Company events looking good.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Good news out after hours. $$$
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Wonder if the convertible debt is done now. Looking like it may be. Gonna get interesting when it dries up.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Made some big buys over the last few days and all of them bared fruit today. Here's to the green mile.
👍️0
mte1955 mte1955 4 años hace
My thoughts exactly. Hopefully the dance continues for this and many other stocks.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Bought a bunch of 4.38's today. Flip forever and ever here. I still think it'll head north eventually.
👍️0
$Money Bags$ $Money Bags$ 4 años hace
Almost all of the convertible debt is extinguished. At current rate, probably in the next 10 days it will be gone at an average of $3ish a share, hence this hard drop. They have growing revenue, could be building the perfect storm. They have plenty of cash on hand. Started buying at $4.50 and have buys down to $3. Any takes on it?
👍️0
Termite7 Termite7 4 años hace
Good chart!!!
👍️0
trustbutverifyit trustbutverifyit 4 años hace
Amazed this board is so quiet on this ticker. It has been hopping on ST for a month now. $10 coming soon.
👍️0

Su Consulta Reciente

NASDAQ
XERS
Xeris Biopharma
ASX
CPTOC
Cipherpoint
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados